Product Previews Atlantic Design/MDM 10 EDS 10 APEX 10 Electronics West/MDM 10 ATE and IPC MW 09 Productronica 09 Atlantic Design/MDM 09 EDS 09 EDS 07 ATExpo & IPC MW 07 Productronica 07 Electronics West/MDM 08 APEX 08 EDS 08 Atlantic Design/MDM 08 SEMICON WEST 08 ATExpo & IPC MW 08 electronica 08 Electronic West/MDM 09 APEX 09

U.S. Tech Part Search Powered by Terms Of Use

HOME> Product Previews> SEMICON WEST 08>

Folder    Article    Weblink    Product    Forum Topic    Calendar    Form    Document    Album    Podcast

Staubli Unveils New Robot for VHP Environments Robotic arm for clean rooms. Duncan, SC — The new STERICLEAN robot from Staubli is going where no other robotics application has effectively gone before — into barrier isolator systems used in aseptic processes in the pharmaceutical, life sciences and medical device industries. According to the company, the innovation represents a major breakthrough in efforts to automate processes within isolators. Using the new robot eliminates repetitive motion concerns and overcomes contamination potential, inconsistency, and throughput issues that impact quality and productivity when human operators pierce an aseptic space. Designed to protect both personnel and products, the robot will withstand corrosive H2O2 (hydrogen peroxide) used during regular sterilization processes by employing complex surface coatings and full encapsulation. The technology eliminates restrictive enclosures and problems related to glove ports and heavy mechanical arms, plus other factors that have undermined previous attempts at using robotics with isolator systems. "Shadow areas," or surfaces on and under the device that might otherwise elude the vaporized hydrogen peroxide, can now be effectively sterilized because the robot is deliberately and methodically moved during sterilization. In addition to addressing product contamination issues, the robots also eliminate the chance that human operators will be contaminated by toxic drugs during syringe filling operations or will suffer from repetitive motion injuries. During extensive testing, the new technology has already demonstrated its ability to simulate human motion and meet productivity goals, raising the rate at which syringes can be filled on a high-speed line from 200 to 800 per minute. The robots can be adapted for a wide range of production needs, from pharmaceutical compounding to cell culturing. Contact: Staubli Corporation, Robotics Div., 201 Parkway West, Duncan, SC 29334 800-257-8235 Web: http://www.staublirobotics.com See at Semicon West Booth #2435.\par